Bioinformatics expertise for RNA bioprocessing
Advanced bioinformatics to enhance expression, stability, and manufacturability
At Quantoom, we bring cutting-edge bioinformatics expertise to mRNA development at a bioprocessing scale.
Designing DNA sequences for RNA vaccine production is a critical yet complex step that directly impacts downstream in vitro transcription (IVT) efficiency and overall bioprocess success.
- We Design RNA sequences from any target antigen
- We Refine RNA sequences for DNA manufacturability
- We Optimize RNA sequences for your target species
- We Tailor RNA sequences for our Ntensify® process
Starting with your specific antigen and target application, our advanced bioinformatics platform designs and optimizes your sequence to enhance expression, stability, and manufacturability.
By leveraging state-of-the-art algorithms and deep expertise in RNA engineering, we deliver a fully optimized, high-performance sequence—ready for in vitro transcription (IVT) and scalable mRNA production.
Our platform goes beyond standard codon optimization, enabling seamless transition from antigen design to fully optimized RNA-based modalities. With our technology-driven approach, we help accelerate the path from concept to scalable mRNA production.
- Highly Manufacturable DNA
- Highly Scalable RNA
- Highly Expressed Antigen
Track record of our N-Force platform
Our N-Force toolbox has demonstrated performances in numerous pre-clinical and target-species evaluation
